NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

TAMA COUNTY — Chronic Wasting Disease (CWD) and Epizootic Hemorrhagic Disease (EHD) continue to impact Iowa’s deer population ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

Wild animals thrive better in the wild where they have plenty of natural habitat with FWP noting it’s safer for humans to ...

Hantavirus explained after Gene Hackman’s wife Betsy Arakawa’s death was confirmed by chief medical examiner Dr Heather ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the ...

University of Maine Cooperative Extension and Maine Department of Agriculture, Forestry, and Conservation are offering a ...